Latest Breaking News On - Triaxial pty - Page 1 : comparemela.com

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has wrapped up its Phase 2 study of the glioblastoma treatment paxalisib. The company has received the final.

United statesTriaxial pty ltdKazia therapeutics ltdDana farber cancer instituteJames garnerFarber cancer institutePatrick wenNovogen limitedTriaxial pty